$bluebird bio (BLUE.US)$ sad sold early 🫠

last and probably least $bluebird bio (BLUE.US)$  all I've done is lose money on this company and will continue to do so because it's one of the first stocks i bought and I like the name , that's all for today but I will continue sharing my hot stocks in brief understandable lingo as i recognize them

$Eton Pharmaceutical (ETON.US)$
$ETON Did anyone really think that Biorphen®, Rezipres®, and Cysteine Hydrochloride all of which are for indications that are not for rare diseases were long term holdings for a rare disease company?
Like they said in their CC, they are now focusing all their $$ into researching and developing therapies for RARE diseases with unmet need They have spent the entire 1H of 2022 establishing a relationship specialist in pediatric endocrinology...